315 results
Page 5 of 16
8-K/A
EX-99.2
na9rl em7zll91n7rk9
19 Sep 19
Special Purpose Combined Statements of Revenues and Direct Expenses
9:26pm
D
djd13zdub1j4msj
26 Jul 19
$27M in equity / options / securities to be acquired, sold $14M, 1 investor
8:15pm
8-K
EX-2.1
a2oo5t8r367t4ski1rbv
19 Jul 19
Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners
5:03pm
8-K
EX-10.1
badr5x5ja9
19 Jul 19
Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners
5:03pm
8-K
EX-10.2
1x9dczgp8teznc4
19 Jul 19
Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners
5:03pm
8-K
EX-1.1
aec24ckp55qqs4p91gxe
28 Jan 19
Interpace Diagnostics Announces Proposed Public Offering of Common Stock
9:40pm
424B5
96hro
28 Jan 19
Prospectus supplement for primary offering
5:29pm
424B5
jud6dbq54bqwjprd
24 Jan 19
Prospectus supplement for primary offering
9:51pm